Yifei Wang
- Molecular Biology top 10%
- Computational Theory and Mathematics top 1%
- Infectious Diseases top 5%
- Materials Chemistry
- Pharmacology top 10%
- Topics
- SARS-CoV-2 and COVID-19 Research (11 papers)Computational Drug Discovery Methods (6 papers)COVID-19 Clinical Research Studies (6 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yifei Wang
80 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 175
- Molecular Biology 842
- Computational Theory and Mathematics 442
- Infectious Diseases 275
- Materials Chemistry 233
- Pharmacology 133
Countries citing papers authored by Yifei Wang
This map shows the geographic impact of Yifei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifei Wang more than expected).
Fields of papers citing papers by Yifei Wang
This network shows the impact of papers produced by Yifei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifei Wang. The network helps show where Yifei Wang may publish in the future.
Co-authorship network of co-authors of Yifei Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Yifei Wang. A scholar is included among the top collaborators of Yifei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifei Wang. Yifei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | Artificial intelligence in drug developmentbreakdown → | 110 |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 5 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 21 | |
| 10 | 3 | |
| 11 | 4 | |
| 12 | 5 | |
| 13 | 67 | |
| 14 | 55 | |
| 15 | 2 | |
| 16 | 6 | |
| 17 | 2 | |
| 18 | 16 | |
| 19 | Early immunoresponse of BALB/C mice to inactivated SARS vaccines prepared with different adjuvants | 1 |
| 20 | Three-dimensional Computer Simulation for Protein Folding | 0 |
About Yifei Wang
Yifei Wang is a scholar working on Infectious Diseases, Reproductive Medicine and Biochemistry, having authored 90 papers that have together received 1.9k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (11 papers), Computational Drug Discovery Methods (6 papers) and COVID-19 Clinical Research Studies (6 papers). The work is most often cited by research in Health Informatics (43 citations), Computational Theory and Mathematics (442 citations) and Infectious Diseases (275 citations). Yifei Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Shengyong Yang, Xin Yang, Ryan Byrne, Gisbert Schneider, Xin Yang, Jun Zou, Jian Yu, Song Lin, Junhua Li and Ajay Singh. Their work appears in journals such as Chemical Reviews, Journal of Biological Chemistry and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.